Trial NCT01114503

View at ClinicalTrials.gov 
Org. Study IDs: 112480
Secondary IDs: 2009-016747-19

Last trial update was posted on 2020-10-30

MeSH Interventions

Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate

MeSH Conditions

Eye Diseases Graves Ophthalmopathy

Other Conditions


Stopping Reasons

Clinical study in Graves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.

Limitations And Caveats

The study was terminated due to the need of better understanding of an efficacious dose with otelixizumab from other clinical studies.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID